Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells (Q39932297)

15 September 2017

title

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells (English)

1 reference

15 September 2017

1 reference

A Berchuck

1 reference

15 September 2017

T Baba

1 reference

15 September 2017

P A Convery

1 reference

15 September 2017

N Matsumura

1 reference

15 September 2017

R S Whitaker

1 reference

15 September 2017

E Kondoh

1 reference

15 September 2017

T Perry

1 reference

15 September 2017

Z Huang

1 reference

15 September 2017

R C Bentley

1 reference

15 September 2017

S Mori

1 reference

15 September 2017

S Fujii

1 reference

15 September 2017

J R Marks

1 reference

15 September 2017

S K Murphy

1 reference

15 September 2017

language of work or name

English

0 references

publication date

6 October 2008

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

209-218

1 reference

Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

NCBI GEO: mining tens of millions of expression profiles--database and tools update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

GATHER: a systems approach to interpreting genomic signatures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Prospective identification of tumorigenic prostate cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

The epigenomics of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Isolation of neural stem cells from the postnatal cerebellum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

The biology of cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Prostate cancer stem cells: a new target for therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

CD133: molecule of the moment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Identification and expansion of human colon-cancer-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Identification of human brain tumour initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Epigenetic stem cell signature in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.374

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.374

1 reference

Dimensions Publication ID

15 September 2017

1038361569

0 references

1 reference